ReutersNovo shares jump ahead of its largest ever drug launchReutersCOPENHAGEN Shares in Novo Nordisk (NOVOb.CO) rose as much as 5 percent on Monday after the U.S. Food and Drug Administration (FDA) approved the diabetes drug Tresiba, allowing the Danish drugmaker to prepare its largest ever drug launch.FDA approves two new drug treatments for diabetes mellitusYumanewsnowNovo Nordisk finally bags insulin degludec approval in USPMLiVETresiba: New Diabetes Drug Was Approved by The FDAWorld Report NowChannel News Asiaall 10 news articles »
Novo shares jump ahead of its largest ever drug launch
Rating: 4.5
Diposkan Oleh: Unknown
